kidney cancer

Test for biomarkers may detect kidney cancer earlyA new immunoassay that tests for the presence of three biomarkers appears to be a valid screening method for the early detection of renal cell carcinoma, according to a recent study.
Novel VEGF inhibitor may play role in advanced renal cell carcinomaUse of tivozanib, an experimental tyrosine kinase inhibitor (TKI) with increased specificity and potency for the vascular endothelial growth factor (VEGF) receptor, as initial targeted therapy for patients with advanced renal cell carcinoma did not translate into improved overall survival compared with sorafenib (Nexavar) in a phase III clinical trial.
Treatment of metastatic RCC: What can we offer?To optimize outcomes for patients with advanced renal cell carcinoma, multimodal therapy is often required.
Study: Surveillance is safe for small renal massesA large retrospective study of older patients diagnosed with small kidney tumors showed that patients who undergo surgery to remove these tumors have the same risk of dying of kidney cancer over a 5-year period as those who undergo surveillance.
Thermal ablation common for small renal massesFindings from a recent survey cement the idea that urology departments at academic centers have adopted thermal ablation as an alternative for management of patients with small renal masses, say researchers from the University of Wisconsin, Madison.
Zero-ischemia nephrectomy appears safe, efficaciousA technique of zero-ischemia robotic partial nephrectomy (RPN) using near-infrared fluorescence imaging appears to be associated with better postoperative kidney function compared with conventional RPN with main-artery renal clamping.
Kidney cancer treatment requires focus, consideration of treatment-associated eventsTreatment of advance kidney cancer has evolved considerably over the last decade, and multiple agents are available.